Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Biol. Res ; 52: 55-55, 2019. ilus, graf, tab
Article in English | LILACS | ID: biblio-1505775

ABSTRACT

BACKGROUND: Epanorin (EP) is a secondary metabolite of the Acarospora lichenic species. EP has been found in lichenic extracts with antimicrobial activity, and UV-absorption properties have been described for closely related molecules; however, its antiproliferative activity in cancer cells has not yet been explored. It has been hypothesized that EP inhibits cancer cell growth. MCF-7 breast cancer cells, normal fibroblasts, and the non-transformed HEK-293 cell line were exposed to increasing concentrations of EP, and proliferation was assessed by the sulforhodamine-B assay. RESULTS: MCF-7 cells exposed to EP were examined for cell cycle progression using flow cytometry, and DNA fragmentation was examined using the TUNEL assay. In addition, EP's mutagenic activity was assessed using the Salmonella typhimurium reverse mutation assay. The data showed that EP inhibits proliferation of MCF-7 cells, and it induces cell cycle arrest in G0/G1 through a DNA fragmentation-independent mechanism. Furthermore, EP's lack of overt cytotoxicity in the normal cell line HEK-293 and human fibroblasts in cell culture is supported by the absence of mutagenic activity of EP. CONCLUSION: EP emerges as a suitable molecule for further studies as a potential antineoplastic agent.


Subject(s)
Humans , Female , Breast Neoplasms/drug therapy , Apoptosis/drug effects , Cell Proliferation/drug effects , Lichens/chemistry , Antineoplastic Agents/therapeutic use , DNA Fragmentation , MCF-7 Cells , Flow Cytometry , Antineoplastic Agents/isolation & purification
2.
Rev. méd. Chile ; 139(5): 613-617, mayo 2011. ilus, tab
Article in Spanish | LILACS | ID: lil-603098

ABSTRACT

Background: Approximately 15 percent of misoprostol-induced-abortions may not be successful, leading to in utero exposure to the drug and to the induction of a series of defects including central nervous system, limb and visceral defects. A commonproposal is that the drug causes disruption of the fetal vasculature leading to embryonic or fetal hypoxia. Aim: To evaluate the teratogenicity of misoprostol using the rat post-implantation embryo culture. Material and Methods: Rat embryos were collected at the beginning of organogenesis and cultured in rat serum containing misoprostol at concentrations of 200, 2,000 or 20,000 pg/ml. Functionality, morphology and morphometry parameters were evaluated. Results: Misoprostol induced a dose-dependent embryotoxic effect causing a decrease in embryo viability and function (poor vascular development and survival) and morphometry (alterations in branchial arches, heart and cephalic portions of the neural tube, among others). Conclusions: All the manifestations observed are indicative of the ability of misoprostol to directly induce developmental retardation and alterations.


Subject(s)
Animals , Female , Pregnancy , Rats , Abnormalities, Drug-Induced/embryology , Abortifacient Agents, Nonsteroidal/toxicity , Embryo, Mammalian/drug effects , Misoprostol/toxicity , Embryo, Mammalian/abnormalities , Mutagenicity Tests/methods , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL